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                               Introduction
Rheumatic heart disease plays a major debilitating role in Indian population causing high morbidity and 
mortality, affecting the population in their productive phase of life. It impairs the quality of life and leads to 
psycho-social and economic burden to their family and the society. With the clinical introduction of 
cardiac valvular prosthesis in 1960, valve replacement has saved a number of lives affected by 
hemodynamically significant valvular heart diseases. 
Prosthetic valve replacement is not with out danger and it became evident that "valve replacement is 
simply exchanging one disease for another". In spite of tremendous strides toward perfecting materials 
and design, the ideal valve remains elusive. Thromboembolism continues to be a major cause of 
morbidity and mortality in patients who have undergone mechanical valve replacement.  
Recent surgical trend in treating rheumatic mitral valve disease is to repair the valve. If repair is not 
feasible, then valve replacement is still undertaken knowing the complications unique to prosthetic 
valve replacement in the interest of saving the life. 
It is well known that traditional mitral valve replacement when compared to mitral valve repair carries 
a higher morbidity and mortality. This has been attributed to the preservation of the mitral subvalvular 
apparatus in repair techniques, but not all valves can be repaired, especially those of rheumatic 
etiology. Mitral valve replacement has been the procedure of choice usually adopted in these 
conditions, but the results have not been comparable. By preserving the annular ventricular continuity 
in mitral valve repair good left ventricle (LV) function in both early and late post operative period has 
been achieved.
 A surgery in which annular-papillary continuity is preserved during replacement has shown better 
early and late results than traditional mitral valve replacement (MVR) techniques. As the awareness of 
the deleterious effects of the loss of annuloventricular continuity has increased chordal preservation 
during mitral valve replacement has gained in popularity.
ANATOMY OF MITRAL VALVE
The mitral valve apparatus consists of leaflets, annulus, chordae tendinae, papillary muscles, and left 
ventricle. Mitral valve and its apparatus play an important role in maintaining the left ventricular 
geometry and function.
ANNULUS:-
The mitral annulus is the area of leaflet attachment to muscular fibers of the atrium and ventricle. The 
annulus is pliable, permitting sphincteric contraction and decreases in diameter during each systolic 
contraction by approximately 26%. The orifice of the mitral valve also changes shape, from elliptical 
during ventricular systole to circular during late diastole. This flexibility increases leaflet coaptation 
during systole and maximizes orifice area during diastole. 
Changes in size and shape of the annulus result from relaxation and contraction of the basoconstrictor 
muscles (bulbospiral and sinospiral bundles). In the horizontal plane the annulus is saddle-shaped. 
Anteriorly, the annulus is attached to the fibrous skeleton of the heart, extending between the two 
fibrous trigones. This limits its pliability and its capacity to dilate with mitral regurgitation (MR). The 
posterior annulus is more flexible and is not attached to rigid surrounding structures. This is confirmed 
by the clinical observation that dilation of the annulus occurs posteriorly with MR. 
Anatomical knowledge of the mitral annulus and surrounding structures is critical to avoid inadvertent 
damage during mitral surgery. The circumflex coronary artery runs laterally around the mitral annulus 
in the posterior atrioventricular groove. The coronary sinus runs more medially in the same groove. 
The artery to the atrioventricular node, usually a branch of the right coronary artery, runs parallel and 
close to the annulus of the anterior leaflet near the posteromedial commissure. The aortic valve is 
situated between the anterior and posterior fibrous trigones. The bundle of His is located near the 
posterior trigone. 
ANNULAR SIZE, SHAPE AND DYNAMICS 
The average mitral annulus cross-sectional area ranges from 5.0 to 11.4 cm2in normal human hearts 
(average is 7.6 cm2).  The posterior annulus circumscribes about two thirds of the mitral annulus. The 
magnitude of change in mitral annular area is in the 20% to 40% range.  Annular area decreases to a 
minimum in early to mid systole. 
The human mitral annulus is roughly elliptical (or D- or kidney-shaped), with greater eccentricity (i.e., 
being less circular) in systole than in diastole, in its most elliptical configuration, the ratio of minor to 
major diameters is approximately 0.75. During the cardiac cycle, annular regions adjacent to the 
posterior leaflet (where the leaflet attaches directly to the atrial and ventricular endocardium) move 
toward (during systole) and away from (during diastole) the relatively immobile anterior annulus 
LEAFLETS:-
The mitral valve has two leaflets, the anterior (aortic) and posterior (mural) leaflets. The leaflets are 
attached to the mitral annulus and at its free border to the papillary muscles by primary and secondary 
chordae. The anterior mitral leaflet is in direct continuity with the fibrous skeleton of the heart. This 
leaflet is contiguous with the left and noncoronary cusps of the aortic valve and the area below the 
intervening aortic commissure, termed the fibrous subaortic curtain. Although the anterior leaflet 
occupies only 35% to 45% of the annular circumference, its leaflet area is almost identical to that of the 
posterior leaflet. 
The posterior leaflet is rectangular. The free margin of the posterior leaflet has two clefts that divide the 
posterior leaflet into three scallops: the largest or middle scallop, the posteromedial scallop, and the 
anterolateral scallop. Fan-shaped chordae insert into and define the clefts between the individual 
posterior scallops. Motion of the posterior leaflet is more restricted than that of the anterior leaflet; 
however, both mitral leaflets contribute importantly to effective valve closure.
The valvular surface area is bigger compared to the orifice area. The ratio is close to 2:1. This 
difference exaggerates even more during systole because of the sphincter action of   annulus which 
reduces further the orifice area.
There are three phases in valve orifice closure.
1) Edge to edge meeting between leaflets.
2) Upward bulge of leaflet.
3) Final phase maximal coaptation of leaflet. Almost they lie vertically. 
The surface of the mitral leaflet is divided into three zones corresponding to areas of chordal insertion 
and leaflet coaptation. The rough zone is the leading edge of the anterior and posterior mitral leaflets. 
This zone is the contact surface of the mitral leaflets during systole. The clear zone is peripheral to the 
rough zone and represents most of the body of the leaflet; this portion of the mitral valve billows into 
the atrium during ventricular contraction. The basal zone, between the clear zone and the annulus, 
receives the insertion of the basal chordae tendinae (tertiary chordae), which originate directly from the 
trabeculae of the left ventricle. The basal zone is found only on the posterior leaflet. 
The histological structure of the leaflets includes three layers: (1) the fibrosa, the solid collagenous core 
that is continuous with the chordae tendinae; (2) the spongiosa, which covers the atrial aspect and forms 
the leaflet leading edge (it consists of few collagen fibers but has abundant proteoglycans, elastin, and 
mixed connective tissue cells); and (3) a thin fibro elastic covering of most of the leaflets. On the atrial 
aspect of both leaflets, this surface (the atrialis) is rich in elastin. The ventricular side of the fibroelastic 
cover (the ventricularis) is much thicker; it is confined mostly to the anterior leaflet and is densely 
packed with elastin. 
CHORDAE TENDINAE:-
The chordae tendinae are chords of fibrous tissue that attach the mitral leaflets to either the papillary 
muscles or the left ventricular free wall. They often subdivide and interconnect before they attach to the 
leaflets. The chordae are divided into primary, secondary, and tertiary chordae. 
Primary chordae attach directly to the fibrous band running along the free edge of the leaflets. These 
chordae ensure that the contact surfaces (rough zone) of the leaflets coapt without leaflet prolapse or 
flail. Secondary chordae attach to the ventricular surface of the leaflets at the junction between the 
rough and clear zones. These chordae contribute to ventricular function. Secondary chordae helps the 
ventricle to contract in an efficient cone-shaped fashion; when secondary chordae are excised, the left 
ventricle assumes a globular shape. Tertiary chordae are unique to the posterior leaflet. They arise as 
strands directly from the left ventricular wall or from small trabeculae to insert into the ventricular 
surface of the leaflet near the annulus. 
PAPILLARY MUSCLES:-
The anterolateral and posteromedial papillary muscles each supply chordae tendinae to both leaflets. 
The two groups of papillary muscles support the anterolateral and posteromedial commissures. It arises 
from the junction of the apical and middle thirds of the ventricular wall. 
The anterolateral papillary muscle receives a dual blood supply from the anterior descending coronary 
artery and either a diagonal branch or a marginal branch of the left circumflex artery. The 
posteromedial papillary muscle receives its blood supply from either the left circumflex artery or a 
distal branch of the right coronary artery. 
Because of the single blood supply to the posteromedial papillary muscle, infarction of the 
posteromedial papillary muscle is much more common. Blood supply comes through a large central 
artery at its base from epicardial vessel then dividing in to network to supply the papillary muscle. The 
occlusion of large central artery severely damages the entire papillary muscle, due to lack of collateral 
blood supply. The occlusion of central artery causes necrosis of the papillary muscle which indeed 
leads to mitral regurgitation.
LEFT VENTRICLE:-
The posterior left ventricular wall and papillary muscles play an important role in leaflet coaptation and 
valve competence. Papillary muscles are aligned parallel to the ventricular wall and attach via chordae 
to the free edges of the valve leaflets. These muscles project from the trabeculae and may be single, 
bifid, or a row of muscles arising from the ventricular wall. During isovolumetric contraction the mitral 
leaflets are pulled downward and together by this interaction. 
Ventricular dilatation may affect the alignment and tension on the papillary muscles and valve 
competence.
ATRIAL FIBRILLATION (AF):- 
This is the commonest rhythm disturbance that accompanies mitral valve disease. In Atrial fibrillation 
walls of the atria shudder fast and atrial contraction will not be present. At the same time ventricular 
rate is fast and irregular due to chaotic bombardment of atrioventricular (AV) node by more than 700 
impulses per minute from the atria. 
The trigger of an AF is a focus of acute localized wall stretch. Occurrence of AF has been consistently 
related to the size of the left atrium. Univariate analysis in one study revealed that the incidence of AF 
was 3% when the left atrial diameter was less than 4.0 cm but increased to 54% if the left atrial 
diameter was more than 4.0 cm, thus explaining the highest incidence in patients with mitral valve 
disease, which causes maximum left atrial enlargement. For AF patients, sinoatrial (SA) node histology 
indicates severe degeneration of normal pacemaker tissue.
It is postulated that fibrosis and degeneration of the atrial myocardium in valvular heart disease, 
especially of rheumatic etiology disturbs impulse propagation in the atria and leads to AF.
Atrial fibrosis probably contributes to persistent AF after valvuloplasty or valve replacement/repair. In 
patients with valvular disease, AF also occurs more frequently with mitral valve calcification, mitral 
valve prolapse and following valve replacement surgery. 
Atrial wall shows myofibrillar changes with increased fibrous tissue deposition, leading to haphazard 
electrical activity. Mechanically there is a loss of atrial contribution to stroke volume by up to 30%. 
Combination of loss of atrial kick and fast ventricular rate (loss of diastolic  filling time) occur  plus 
loss of  normal presystolic closure timing of atrioventricular valves   due to fast ventricular rate and 
absent atrial contraction, all of which  decreases  cardiac output and mitral regurgitation may occur.
Dilatation of atrial wall leads to increased secretion of atrial natriuretic peptide. Fast heart rate 
precipitates congestive cardiac failure by tachycardia mediated cardiomyopathy there by AF per se is 
responsible for overt heart failure by increasing myocardial metabolism by provoking rapid myocardial 
contraction leading to exhaustion. 
Dilated atrium, loss of atrial contraction is factor for clot formation. After the onset of AF, stroke is the 
most feared and calamitous complication. Compared to sinus rhythm AF  carries an increased mortality 
of about 1.5- 1.9  independent of heart disease and age and part of this increased mortality is likely due 
to stroke in its various presentation.
EVIDENCE BASED TREATMENT
The Committee on Management of Patients with Valvular Disease was given the task of reviewing and 
compiling this information base and making recommendations for diagnostic testing, treatment and 
physical activity. These guidelines follow the format established in previous American College of 
Cardiology / American Heart Association (ACC/AHA) guidelines for classifying indications for 
diagnostic and therapeutic procedures:
Class I:  Conditions for which there is evidence and / or general agreement that a given procedure 
or treatment is useful and effective.
Class II: Conditions for which there is conflicting evidence and/or a divergence of opinion about 
the usefulness/efficacy of a procedure or treatment.
IIa:      Weight of evidence/opinion is in favor or usefulness/ efficacy 
IIb: Usefulness/efficacy is less well established by evidence/opinion.
Class III: Conditions for which there is evidence and/or general agreement that the 
procedure/treatment is not useful and in some cases may be harmful.
INDICATION FOR MITRAL VALVE REPLACEMENT
Indications for valve replacement pertain to those types of valve that are unlikely to be repaired or 
which have been shown to have poor long-term success after previous intervention. 
MITRAL STENOSIS (MS)
Mitral stenosis is almost exclusively caused by rheumatic fever. The pathologic changes in rheumatic 
valvulitis are mainly fusion of the valve leaflets at the commissures; shortening and fusion of the 
chordae tendinae; and thickening of the leaflets due to fibrosis, contraction and calcification. 
Stenosis usually develops one or two decades after the acute illness of rheumatic fever with no or slow 
onset of symptoms until the stenosis becomes more severe. Limitation of exercise tolerance is usually 
the first symptom followed by dyspnea that can progress to pulmonary edema. New onset atrial 
fibrillation and risk for thromboembolism, hemoptysis, and pulmonary hypertension are other common 
symptoms in patients with mitral stenosis. 
The diagnostic workup of the symptomatic patient with mitral stenosis should include a complete 
cardiac catheterization, including coronary angiography in any patient over the age of 40. Under the age 
of 40, echocardiography findings of the mitral valve is enough   in most symptomatic patients for the 
definition of mitral valve pathology unless there is a history of chest pain or coronary artery disease. 
In general, operation is prescribed when the mean valve area is 1.0 cm2 or less (normal mitral valve 
area: 4–6 cm2 - however, with a "mixed" lesion of mitral stenosis and mitral regurgitation, the valve 
area in symptomatic patients occasionally may be as large as 1.5 cm2. Asymptomatic patients are 
generally not considered for surgery but it is in the asymptomatic patients with significant 
hemodynamic mitral stensosis, still surgery is considered. 
ACC / AHA RECOMMENDATIONS FOR MITRAL VALVE REPLACEMENT IN 
MITRAL STENOSIS
1. Patients with moderate or severe mitral stenosis (mitral valve area ≤1.5cm2) and NYHA 
functional Class III-IV symptoms who are not considered candidates for percutaneous balloon 
valvotomy or mitral valve repair – Class I
2. Patients with severe mitral stenosis (mitral valve area ≤ 1 cm2) and severe pulmonary 
hypertension (pulmonary artery systolic pressure > 60 to 80mm Hg) with NYHA (New York 
Heart Association) functional Class I-II symptoms who are not considered candidates for 
percutaneous balloon valvotomy or mitral valve repair – Class IIa.
MITRAL REGURGITATION (MR)
The etiology of mitral regurgitation is very diverse. Except in cases of acute ischemic mitral 
regurgitation and endocarditis, where indications are more straightforward. Indication generally for 
regurgitative lesion is complex. Etiology of regurgitation are degenerative (mitral prolapse, 
ruptured/elongated chordae), rheumatic, infectious and ischemic diseases of the mitral valve. Most of 
these are now amenable to mitral valve repair and reconstruction.
For any of the preceding major pathologic subsets, indications for surgery in patients with mitral 
regurgitation vary from the asymptomatic patient with an enlarging but well functioning left ventricle 
and atrium to severely depressed left ventricular function. Any symptomatic patient with significant 
mitral regurgitation (3+ to 4+) should be operated on, and operation should be considered in any 
relatively symptom free individual if there is objective evidence of left ventricular deterioration and 
significant increase in left ventricular end-systolic and end-diastolic volumes.
Regurgitation through the valve is usually measured with Doppler echocardiography, but magnetic 
resonance imaging (MRI) is another noninvasive technology for measuring the regurgitant flow and can 
provide measurements of ventricular end-diastolic/systolic volumes and ventricular mass. Left 
ventricular angiography with coronary angiogram can be helpful but is otherwise indicated for 
evaluating the coronary arteries preoperatively in patients older than 40 years. 
It is important to stress that ejection fraction is a poor indicator of left ventricular function in patients 
with mitral regurgitation. Depressed cardiac output (< 40%) therefore usually indicates severe left 
ventricular dysfunction, and results of surgery are not as favorable in these patients as they are in 
patients with normal ventricles. Compared to ejection fraction, measurements of end-systolic volume 
and diameter are more reliable noninvasive parameters to evaluate the status of the left ventricle and 
determine the optimal time for operation.
 Carpentier et al classified mitral regurgitation into three pathoanatomic types based on leaflet and 
chordal motion: normal leaflet motion (type I), leaflet prolapse or excessive motion (type II), and 
restricted leaflet motion (type III). Type III is further subdivided into "a" and "b" based on leaflet 
restriction during diastole (type IIIa) or during systole (type IIIb), as typically seen in patients with 
ischemic mitral regurgitation (IMR).
Mitral regurgitation with normal leaflet motion is caused by annular dilation, which is often secondary 
to left ventricular dilation; as a rule, insufficient leaflet coaptation area or incomplete mitral leaflet 
coaptation is present. Examples include patients with dilated cardiomyopathy and some with ischemic 
heart disease complicated by ischemic mitral regurgitation (IMR). Normal leaflet motion is also 
associated with leaflet perforation secondary to endocarditis. 
Leaflet prolapse typically results from a floppy mitral valve with chordal elongation and/or rupture, but 
can be seen in patients with coronary artery disease who have papillary muscle rupture or rarely 
papillary muscle elongation. Mitral regurgitation due to restricted leaflet motion is associated with 
rheumatic valve disease (type IIIa and type IIIb), ischemic heart disease (IMR with type IIIb restricted 
systolic leaflet motion with or without annular dilation), and dilated cardiomyopathy (type IIIb plus 
annular dilation). 
In chronic mitral regurgitation the left ventricular function gradually declines. The regurgitant volume 
into the left atrium during systole is added to the forward stroke volume and tends to increase the total 
forward output and ejection fraction in early phase. However progressive left ventricular dilation 
increasing the wall tension which leads to increased systolic wall stress and afterload. After mitral 
valve replacement, with rapid rise in the afterload, adaptation of the left ventricle to this change is 
based on the annulo ventricular continuity.
Fixation of the mitral annulus with a rigid prosthesis interferes with the distention and contraction of 
the basoconstrictor. Also after mitral valve replacement the left ventricular volume decreases because 
of the elimination of the regurgitant left atrium (LA) volume. After mitral valve replacement with 
chordal transection the ejection fraction (EF) is determined by contractility; preload and after load. 
Afterload is increased because of loss of low impedance pathway into LA; also reducing preload is the 
loss of regurgitant LA volume plus a residual gradient across the prosthesis impedes left ventricular 
filling.
All this contributes to a low cardiac output syndrome despite satisfactory prosthetic valve function. All 
the above mentioned problems were not seen with traditional mitral valve repair technique.
ACC/AHA RECOMMENDATIONS FOR MITRAL VALVE SURGERY IN 
NONISCHEMIC SEVERE MITRAL REGURGITATION
1. Acute symptomatic mitral regurgitation in which repair is likely – Class I.
2. Patients with NYHA functional Class I, III, or IV symptoms with normal left ventricular function defined as 
ejection fraction > 0.60 and left ventricle end-systolic dimension (LVeSD) < 45 mm – Class I.
3. Symptomatic or asymptomatic patients with mild left ventricular dyfunction, ejection fraction 0.50 to 0.60, 
and end-systolic dimension 45 to 50 mm – Class I. 
4. Symptomatic or asymptomatic patients with moderate left ventricular dysfunction, ejection fraction 0.30 to 
0.50, and / or end-systolic dimension 50 to 55 mm – Class 1.
5. Asymptomatic patients with preserved left ventricular function and atrial fibrillation – Class IIa.
6. Asymptomatic patients with preserved left ventricular function and pulmonary hypertension (pulmonary artery 
systolic pressure > 50mm Hg at rest or > 60 mm Hg with exercise) – Class IIa
7. Asymptomatic patients with EF 0.50 to 0.60 and left ventricle end-systolic dimension <45 mm and 
asymptomatic patients with ejection fraction > 0.60 and left ventricle end-systolic dimension 45 to 55 mm – Class 
IIa.
8. Patients with severe left ventricular dysfunction (ejection fraction < 0.30 and / or end-systolic dimension > 55 
mm) in whom chordal preservation is highly likely – Class IIa.
9. Asymptomatic patients with chronic MR with preserved left ventricular function in whom mitral valve repair 
is highly like – Class IIb.
10. Patients with mitral valve prolapse and preserved left ventricular function who have recurrent ventricular 
arrhythmias despite medical therapy – Class IIb.
11. Asymptomatic patients with preserved left ventricular function in whom significant doubt about the feasibility 
of repair exists – Class III.
REVIEW OF LITERATURE
Cardiac valve repair or replacement under direct vision awaited the development of the heart-lung 
machine. With the contribution by John Gibbon to the development of the heart-lung machine, valve 
replacement becomes feasible. 
The first successful prosthetic mitral valve replacement was done by Nina Braunwald in 1960 1. This 
was followed by Starr and Edwards,   replacing the   mitral valve with a caged ball valve in September 
1960, from then problems of post operative low cardiac output, thromboembolism, anticoagulation 
related bleeding came to the fore 2.
The first mitral valve prosthesis was implanted on Sept 21 1961 by Albert Starr and Edwards from 
University of Orgean. Problems of post op low cardiac output, thromboembolism, anticoagulation and 
bleeding came to the fore3. 
Central flow design offers a lower transvalvular gradient, durable, thromboresistance, low incidence of 
valve related adverse events. Of the more than 70 mechanical valves in clinical usage the St Jude 
medical valve has been the most successful and has been the gold standard for mitral valve replacement 
4, 5, 6, 7, 8 in all age groups, from infant to the elderly 9,10,11,12,13,14.
According to Crawford etal the immediate operative mortality for valve replacement may not be related 
to the type of prosthesis used 15.
Lim etal reported from their study that Carbomedics and St Jude valve had no significant difference in 
early and midterm clinical outcomes. The choice with respect to valve type can be based on other than 
patient outcomes 16.
Ye-Ying Cen etal in their analysis of Carpentier-Edwards bio prosthesis and St Jude mechanical valve 
found, 10-year survival was not statistically different between the two but factors predicting adverse 
survival after mitral valve replacement were older age, lower ejection fraction, presence of class IV 
congestive heart failure, coronary artery disease, renal disease, smoking history, hypertension, 
combined valve surgery, and redo heart surgery. Choice of biologic or mechanical prosthesis does not 
significantly affect long-term patient survival after mitral valve replacement 17.
According to Ikonomidis etal   valve replacement patients do not survive in parallel to normal 
population.  Factors influencing the operative mortality are age, previous valve replacement, cardiac 
function, coronary artery disease. These factors influence on operative mortality than the type of valve 
prosthesis implanted. Late death is unrelated to prosthetic valve, and the factors influencing the long 
term outcome is higher NYHA (New York Heart Association) class, concomitant CABG, increasing 
age 5.
Remadi etal in their study identified age and sex as significant risk factors for valve-related mortality 
and that higher age, female sex, higher NYHA class, and atrial fibrillation had significant correlation 
with overall higher mortality 6.
In 1922 Wiggers and Kats and later Rushmer et al proposed the concept of annulo -ventricular 
continuity. According to this concept, the LV geometry and function are a result of a dynamic 
interaction between mitral annulus and left ventricular wall. The attachment between the mitral annulus 
and LV wall moderates the LV distensibility during diastole and wall stress during systole18. 
In 1960 McGoon and colleagues described an effective repair for MR due to ruptured chordae19. 
In 1964 Lillehei introduced the concept of chordal preservation during mitral valve replacement to 
reduce the problems of post operative low cardiac output syndrome. But his observations went 
unheeded at that point of time20, 21.
In the original technique described by Lillehei the posterior leaflet was bound to the annulus with a 
running stitch. He reported a reduction of peri operative, mortality from 37% to 14%20.
During the same period Mitral valve repair gained acceptance by removing the need for anticoagulation 
and better left ventricular function and hemodynamics afforded by it.
In1981 David reintroduced the concept of annulo ventricular continuity after extensive experiments in 
canine models with mitral valve replacement. He introduced the concept of total chordal preservation22, 
23, 24.
In the technique originally described by him the anterior mitral leaflet (AML) is incised at its base and 
carried to both sides and brought centrally towards the free edge of the leaflets and a triangular segment 
of the leaflet is excised leaving the chordae attached to the free edge which is resuspended to the mitral 
annulus by sutures used to secure the prosthetic valve. 
The posterior mitral leaflet with its chordae is left intact, in patients with myxomatous mitral 
regurgitation undergoing mitral valve replacement. Chordae are shortened by imbricating the posterior 
mitral leaflet in the mitral annulus using sutures used for mitral valve (MV) fixation. The advantage he 
claimed with this technique was that the chordae were maintained in their natural anatomic location 
with reduced risk of left ventricular outflow tract obstruction (LVOTO) with the reduction in the bulk 
of leaflet tissues.  
Miki Goor and Hennin and their colleague’s clinical result suggested that chordal preserving during 
mitral valve replacement improved hospital survival and global left ventricular function. Carabello’s 
group again documented preservation of systolic ejection performance in mitral valve replacement with 
chordal preservation.
In 1985 Feike et al reported a technique where the anterior leaflet was split from the centre of the free 
edge to the annulus. Incisions were made on either side of the split towards the commisures to detach 
the anterior mitral leaflet from the annulus.
The remaining two halves of the leaflet were left with the intact chordae. Leaflet was trimmed to 
remove thickened and calcific areas and then rotated posteriorly and sutured to the posterior mitral 
annulus. This technique was suitable in implanting tilting disc prosthesis where disc entrapment by the 
subvalvar apparatus was of concern25.
Disadvantages reported were that this disturbs the normal geometry and relationships of mitral 
subvalvar apparatus which could alter the distribution of the left ventricular wall stress, disturb chordal 
tension during papillary muscle contraction thereby reducing the global left ventricular systolic and 
diastolic function.
In 1988 Khonsari et al described a technique of total chordal preservation where after detaching the 
annulus between the two commisures an ellipse of tissue was excised and the rim of leaflet tissue 
containing chordae was attached to the annulus (Khonsari I).  If leaflet was thickened and calcified it 
was then divided into 2-5 segments bearing chordae which were re attached to the annulus (Khonsari 
II). Posterior mitral leaflet was retained in toto. Using this technique no left ventricular outflow tract 
obstruction or prosthetic function impairment was claimed26.
Myocardial rupture was prevented by maintaining the tethering effect of the intact sub valvar 
apparatus. 
In1988 Miki's described a technique to maintain more normal chordal tension wherein anterior mitral 
leaflet was incised and separated from annulus and divided at its center, anterior and posterior 
commisures were incised and papillary muscles were slit, excessive cuspal tissue and fibrous calcific 
nodules were excised. The two chordal segments thus created were sutured to the respective antero 
lateral and posteromedial commisures. 
Posterior mitral leaflet was incised in center and prosthetic valve seated in position plicating the 
posterior mitral leaflet and including the posterior mitral leaflet and chordae in the sutures for securing 
valve. Advantages claimed were that this technique was simple, there is no left ventricular outflow tract 
obstruction, allows a larger prosthesis to be seated and very well suited for low profile valves27.
In 1990 Rose and Oz described a technique were the anterior mitral leaflet was stretched posteriorly 
and a central portion was excised, the rim of the remaining leaflet tissue containing the marginal 
chordae, defect in the anterior mitral leaflet was closed with a running suture parallel to the annulus. 
Valve sutures reinforced the previous suture line. Prosthetic valve was sutured to orient the leaflets 
perpendicular to the native orientation28.
There were low chances of left ventricular outflow tract obstruction with reduced bulk of leaflet tissue, 
reduced risk of thrombosis on the residual leaflet29, 30.
Vander Slam described yet another technique for preserving anterior leaflet31.
Sarris et al demonstrated that in an open chest swine model the changes induced by chordal transection 
could be completely reversed by reattaching papillary muscle to the mitral annulus32, 33.
Experiments by Hansen and associates demonstrated that left ventricular function was superior with 
intact subvalvar apparatus, intermediate with preservation of posterior mitral leaflet alone and poorest 
with loss of all chordae33.
Horskote et al showed that partial chordal preservation preserving posterior mitral leaflet alone 
improved event free survival34.
Hennein et al showed that after chordal excision, exercise capacity, left ventricle end-systolic 
dimension and cardiac index did not improve and that the left ventricular function declined. In contrast 
after preservation of the entire sub valvar apparatus the exercise capacity improved markedly, left 
ventricular function improved and early ejection fraction improved 22
David et al reported results in patients undergoing redo mitral valve replacement after initial mitral 
valve replacement, where all chordae were transected. 4-0 PTFE (poly tetra fluro ethylene) sutures were used 
to create new chordae if they were transected previously. Incidence of low cardiac out put and operative 
mortality was low in the chordal preservation and reconstruction group36.
Hetzers study reported major advantages of chordal preservation in the form of reduction in the 
mortality, improved early and late left ventricular function, improved long term survival and 
elimination of the risk of the dreaded complication of midventricular rupture37.
Hassan Mottcha et al in their study noted that total chordal preservation did not cause left ventricular 
tract obstruction after mitral valve replacement38.
Ghiskine Deklunder et al in their prospective study noted that anterior chordal transaction impairs not 
only regional left ventricular function but also regional right ventricular function in mitral 
regurgitation.39 
AIMS AND OBJECTIVES
The aim in this study was to study in retrospect the possible out come benefits of chordal sparing 
surgery when mitral valve replacement is done for rheumatic mitral disease in terms of left ventricular 
function by assessing parameters of left ventricular systolic and diastolic function.
The parameters  assessed were hemodynamic stability in the immediate peri and post operative period, 
left ventricular ejection fraction preoperative and postoperative, left ventricular end systolic and 
diastolic dimensions pre and postoperative .
MATERIALS AND METHODS
All patients who underwent mitral valve replacement between January 2008 and December 2008 for 
isolated mitral valve disease are studied. Patients with other valvular (aortic, tricuspid & pulmonary) or 
congenital cardiac defects requiring additional intervention were excluded from the study. 
One hundred and fifty two patients underwent mitral valve replacement surgery for chronic mitral 
valve disease, in 86 of these procedures the classical mitral valve replacement technique was followed 
and in 66 patients chordal sparing technique was followed. 
In both group of patient’s preoperative NYHA class, left ventricular end systolic, end diastolic 
dimensions and preoperative ejection fraction were noted. Surgery was conducted with a standard 
midline sternotomy incision, bicaval and aortic cannulation. Core was cooled to 28°C. 
Heart was arrested with hyperkalemic blood cardioplegia, with topical ice slush being used to cool 
myocardial temperature further. Left atrium was opened parallel to the interatrial groove. Surgery was 
conducted after inspecting the valve and suitability for chordal preservation assessed.
In all cases St Jude mechanical bileaflet prosthetic valve was used. Suturing was done with 
continuous / interrupted 2-0 ethibond suture in the classical mitral valve replacement patients or after 
plicating the posterior leaflet with the valve fixation suture in the posterior mitral leaflet area. 
All patients were electively ventilated post operatively with inotropic supports being dictated by the 
hemodynamics of the patient. 
The patients out come after surgery where the subvalvar apparatus was preserved either completely or 
partially were compared against the group in whom the classical technique was followed. The variables 
assessed were post operative needs for and dosage of multiple inotropic supports, duration of ventilator 
support. 
Post operative left ventricular function was assessed with a pre discharge echo cardiography. The 
parameters noted were the left ventricular end systolic and end diastolic dimensions post operative left 
ventricular ejection fraction, reduction in NYHA class. 
TABLES
TABLE NO 1: AGE DISTRIBUTION
Patient (years ) Classical MVR (86) Chordal Spr MVR (66 )
11 – 20 9 12
21 – 30 27 25
31 – 40 22 14
41 – 50 25 12
51 – 60 3 3
0
5
10
15
20
25
30
11. - 20 21 – 30 31 – 40 41 – 50 51 - 60
Age Distribution
Classical MVR (86)
Chordal Spr MVR (66 )
TABLE NO 2: SEX DISTRIBUTION
Sex Classic MVR ( 86 ) Chordal Spr MVR ( 66 )
Female 48 40
Male 38 26
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TABLE NO 3: SYMPTOMS
NYHA Class Classic MVR ( 86 ) Chordal Spr MVR ( 66 )
I - -
II - -
III 4 5
IV 82 61
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0 0 4
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TABLE NO 4: EJECTION FRACTION
Ejection Fraction Classic MVR ( 86 ) %
Chordal Spr MVR 
( 66 ) %
> 60 % 1 1 4 6
50 – 59 % 13 15 24 36
40 – 49 % 63 73 37 56
< 40 % 9 11 1 2
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TABLE NO 5: LV END SYSTOLIC DIMENSION
LV eSD (mm) Classic MVR 
( 86 )
% Chordal Spr MVR 
( 66 )
%
> 50 - - - -
40 – 49 11 13 8 12
30 – 39 65 75 55 83
20 – 29 10 12 3 5
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TABLE NO 6:  RHYTHM
Rhythm Classic MVR ( 86 ) % Chordal Spr MVR (66 ) %
Sinus 22 26 22 33
Atrial Fib 64 74 44 67
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TABLE NO 7: SURGERY
Surgery Technique No of cases %
Classic MVR 86 57
Chordal Spr MVR 66 43
Surgery
57%
43%
Classic MVR
Chordal Spr MVR
TABLE NO 8: VENTILATOR SUPPORT
Ventilator time <24 Hrs % 24 – 48 Hrs % >48 Hrs %
Classic MVR ( 86 ) 42 49 43 50 1 1
Chordal Spr MVR      ( 66 
)
50 76 16 24 - -
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TABLE NO 9: MORBIDITY AND MORTALITY
Morbidity/Mortality Classic MVR 
( 86 )
% Chordal Spr MVR 
(66 )
%
Re-exploration 2 2 3 5
Wound Infection 5 6 5 8
Low output state 5 6 3 5
Mortality 5 6 2 3
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TABLE NO 10: INOTROPIC SUPPORT
Inotrope Classic MVR (86) %
Chordal Spr MVR 
(66) %
Dop/Dob 49 57 60 91
Dop/Dob+Adr 31 36 5 8
Dop/Dob+Adr+Iso 6 7 1 1
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TABLE NO 11: PRE DISCHARGE ECHO 
ECHO EF Decrease
EF 
Increase/same
LV ESD 
Increase/same
LV EDD 
Decrease
Classic 
MVR (86)
75 (87%) 11 (13%) 33 (38%) 74 (86%)
Chordal Spr 
MVR (66)
45 (68%) 21 (32%) 7 (11%) 59 (89%)
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OBSERVATION
A total of 152 patients underwent mitral valve replacement for isolated mitral disease during January 
2008 to December 2008. Of this 86 patients (57%) had classical mitral valve replacement and 66 
patients (43%) had chordal sparing mitral valve replacement. Lillehei and David technique were 
followed in chordal preservation group. All patients had St Jude Bileaflet mechanical valve.
TABLE NO 1: AGE DISTRIBUTION.
In both group majority of the patients were in the second decade with a minimum age of 11 yrs and 
maximum of 59 yrs. Of the 86 patients in classical mitral valve replacement group majority were nearly 
equally distributed in second, third and fourth decade. Minimum age was 11 yrs and maximum was 59 
yrs in this group. 
In the chordal sparing group of 66 patients, majority were in the second decade. Minimum age was 13 
yrs and maximum was 56 yrs.12 patients were there in the fourth decade and 14 were there in the third 
decade in chordal sparing group compared to 25 and 22 in the classical group respectively. 3 patients 
were there in fifth decade in both groups. All patients above 50 yrs had coronary angiogram and had 
normal coronary arteries.
TABLE NO 2: SEX DISTRIBUTION.
Of the 152 patients 88 were females (58%) and 64 were males (42%). Distribution in the classical 
mitral valve replacement group was 48 (56 %) females and 38 (44%) males. In the chordal sparing 
group 40 (61%) were females and 26 (39%) were males.
TABLE NO 3: SYMPTOMS.
Majority of the patients were in NYHA class IV in both group of patients. 82 (95%) and 61 (92%) were 
in NYHA class IV in classical and chordal sparing group respectively. 4 (5%) and 5 (8%) in classical 
and chordal sparing mitral valve replacement group respectively presented with NYHA class III 
symptoms. No patients had class I or class II symptoms.
TABLE NO 4: EJECTION FRACTION.
Majority of the patients had there ejection fraction in 40 to 49% range. In classical group 63 patients 
(73%) had EF in 40 to 49 % range compared to 37 patients (56%) in chordal sparing group in the same 
range. In classical group 16 % had EF above 50% and 11% had EF less than 40%. In chordal sparing 
group 42% were above 50% EF and 2% patients were having EF less than 40%.
TABLE NO 5: LV SYSTOLIC DIMENSION.
Left ventricular end systolic and end diastolic dimensions were measured pre operatively and post 
operatively. None of the patients had LVeSD above 50 mm. 11 (13%) and 8 (12%) patients had 
LVeSD in 40 to 49mm range respectively in classical and chordal sparing group. Majority had there 
LVeSD in 30 to 39mm range which include 65 (75%) in classical group and 55 (83%) in chordal 
sparing group. In classical mitral valve replacement group 10 patients had LVeSD in 20 to 29 mm 
range compared to 3 (5%) in the other group.
TABLE NO 6: RHYTHM.
Atrial fibrillation was present in 64 (74%) of 86 patients in classic mitral valve replacement group and 
in 44 (67%) of 66 patients in chordal sparing group. In both group 22 patients had sinus rhythm.
TABLE NO 7: TYPE OF SURGERY.
Of the 152 patients with mitral valve replacement, 86 (57%) had classical mitral valve replacement 
surgery and 66 (43%) had chordal sparing mitral valve replacement surgery.
TABLE NO 8: VENTILATOR SUPPORT.
In the chordal sparing mitral valve replacement group 50(76%) needed less than 12 hrs ventilator 
support and the remaining 16(24%) needed support more than 24 hrs but less than 48 hrs. In the 
classical mitral valve replacement group 42(49%) had ventilator support for less than 24 hrs and 
44(51%) had support more than 24 hrs out of which one needed support for more than 
48 hrs.
TABLE NO 9: MORBIDITY AND MORTALITY.
Five patients were re-explored for excessive drain in chest tube postoperatively of which 2 was in 
classical and 3 in chordal sparing group respectively. In both group five patients had superficial 
surgical site infection which responded to medical management. In classical mitral valve replacement 
group 5 patient had low cardiac output postoperatively as compared to 3 patients in chordal sparing 
group.
A total of 7 deaths were noted in the total 152 mitral valve replacement group. Of this 5 (6%) were in 
classic group with mortality rate of 3.28% and 2 (3%) were in chordal sparing group with mortality rate 
of 1.31%. The deaths were due to low cardiac output syndrome with prolonged ventilator support and 
multiorgan failure in 5 patients and arrhythmia not amenable to medical management in two patients in 
classical group.
TABLE NO 10: INOTROPIC SUPPORT
In classical mitral valve replacement group 49(57%) required dopamine / dobutamine or both post 
operatively compared to 60(91%) in chordal sparing group. 31 (36%) patients required addition of 
adrenaline in classical group compared to 5 (8%) in chordal sparing group. Of the 86 classic mitral 
valve replacement 6 (7%) required both adrenaline and isoprenaline and 1 (1%) patient in chordal 
sparing group required the same.
TABLE NO 11: PRE DISCHARGE ECHO.
There was increase in ejection fraction in 11 (13%) patients in classical group and 21 (32%) patients in 
chordal sparing group. A reduction in LVeSD was present in 62% of classic group and in 89% in 
chordal sparing group. The left ventricular end diastolic dimension (LVeDD) decrease was present in 
86% of classical group and 89% of chordal sparing group.
DISCUSSION
The majority of the patients in this group were in their second decade of life. This is in contrast to the 
age group usually observed in the western population where the majority of the population is in the 5th 
and 6th decade. In the western population the mitral valve prolapse or ischemic mitral regurgitation 
predominates whereas in Indian population rheumatic heart disease predominates. 
Kirklin describes an accelerated form of rheumatic heart disease (RHD) occurs in certain geographical 
areas where severe mitral stenosis or mitral regurgitation is noticed in a younger age group. The 
interval before appearance of symptomatic MR is also shorter than for stenosis with a higher chance for 
previous severe attack of rheumatic fever 40.
The majority of the patients in this group were females. The major etiology of regurgitation or stenosis 
was rheumatic heart disease. Ling et al in their series of chronic mitral regurgitation noticed 70% of 
their study group to be males. The majority of cause of regurgitation in their group was a flail leaflet 
due to ruptured chordae37. According to Ikonomidis etal study 60% were females affected by rheumatic 
etiology and mitral regurgitation being the major presentation5.
  In Demirag etal study, 58.7% were females. The reason for operation was combined mitral stenosis 
plus regurgitation in 36.96% and etiology being acute rheumatic fever in 75.36%8.
The majority of patients in this group were in NYHA class IV. This was noticed for both the chordal 
sparing and classical mitral valve replacement group. No patients were in NYHA class II or class I. 
This is of particular significance because symptom severity is one of the preoperative predictor of post 
operative left ventricular function41.
Grigioni et al in their study of 109 patients with mitral disease noted that the majority of patients in 
their series were in NYHA class III. Rosen et al in their study of 31 patients with severe mitral 
regurgitation due to mitral valve prolapse (MVP) were in class III state42.
The ejection fraction preoperatively in majority of the patient in this study was in the normal or low 
normal range. Enrique’s Sarano et al reported preoperative ejection fraction as a predictor of late out 
come after mitral valve surgery. 
Though ejection fraction is considered to be load dependent it is of considerable significance in post 
operative predictor of out come following mitral valve replacement. In their work on echo cardio 
graphic prediction of left ventricular function Zile MR  and Fleming et al report an ejection fraction of 
lesser than 50% as a  cut off point in mitral regurgitation wherein left ventricular systolic dysfunction is 
said to set in.
Zile MR and Fleming et al report larger left ventricular end systolic dimension greater than 50mm or 
left ventricular end systolic volume index of greater than 50ml/sq m has greater predictor value among 
all the echo indices for left ventricular dysfunction post mitral valve replacement 43.
Alternative proposed measures include end systolic wall stress index, an end diastolic dimension 
greater than 70mm, increased left atrial size. Crawford et al in their operative report on 48 patients 
noted that a low ejection fraction or higher left ventricular end systolic dimension was an important 
predictor of poor late post operative out come44.
A total of 108 patients in both the group were in atrial fibrillation with higher no in the classical group. 
Preoperative atrial arrhythmias have a bearing on the out come in the early phase after surgery26. Type 
of surgery for mitral disease has a bearing on both the early and late out come after mitral valve 
surgery.
Akins et al indicate that mitral valve replacement is a risk factor for late mortality in comparison with 
mitral valve repair in univariate analysis. Gilinov et al found by both univariate and multivariate 
analysis that mitral valve replacement was a risk factor, in comparison to repair45,46.
Higher inotropic supports were needed in 6 of the chordal preserving mitral valve replacement and 37 
of the classical mitral valve replacement patients. They also had to be supported on ventilator for a 
higher period of time (>24 hrs).
The overall mortality in this series was 4.6% with a mortality of 3.28% in the classical group and 
1.31% in the chordal sparing group. The cause of death being low cardiac out put state with multi organ 
failure. Enriquez Sarano et al in their report from Mayo Clinic report a surgical mortality of 2.6% for 
valve repair and 10.3% for replacement with a late survival of 58% at 10 years following mitral valve 
replacement 47.
After valve replacement for chronic mitral regurgitation ejection fraction is lower than preoperatively 
in most patients. Patients undergoing mitral valve repair have better postoperative ejection indices than 
similarly matched patients with valve replacement. Left ventricular hypertrophy did not reduce 
appreciably in mitral valve replacement in comparison to the valve repair group 37, 39. 
SUMMARY
One hundred and fifty two cases of mitral valve replacements were carried out between January 2008 
and December 2008. Of these eighty six patients had classical mitral valve replacement surgery and 
sixty six patients had chordal sparing mitral valve replacement. Most of the patients operated were in 
NYHA class IV. Most of these patients affected were in the second decade with females outnumbering 
males.
Ejection fraction preoperatively was normal or low normal in majority of patients with both classical 
mitral valve replacement and chordal sparring mitral valve replacement. One hundred and eight 
patients had preoperative atrial fibrillation.
In chordal sparing mitral valve replacement group the need for prolonged postoperative ventilator 
support and higher inotropic supports was not seen. In the classical mitral valve replacement group 44 
patients required prolonged ventilation support of greater than 24 hours.
There were seven deaths in this series, two in the chordal sparing mitral valve replacement and five in 
the classical mitral valve replacement group. Postoperative echo showed a significant improvement in 
the ejection fraction and decrease in end systolic dimension in the chordal sparing mitral valve 
replacement group.
CONCLUSION
Mitral valve replacement cannot normalize the life expectancy. Valve replacement has its own 
limitations. Valve replacement is not the end of the disease but a new beginning of a chronic disease 
lying dormant, ready to blow off at any time, given a chance.  
The best way to address   this issue is to stress the importance of mass education, school health 
education, strict implementation of secondary prophylaxis and an early clinical   trial for vaccines for 
rheumatic fever. In failed cases earlier intervention should be done and not to wait until the heart fails 
or atrial fibrilation sets in. 
Timely intervention   when the valve is suitable for conservative procedures and to promote valve 
sparing surgery as much as possible, there by avoiding the prosthetic valve. In the established cases 
conservative surgery in the form of chordal preservation should be done with antiarrythymic surgery 
whenever possible.
In our study of the 66 chordal sparing mitral valve replacement group, better hemodynamics were 
noted both in the immediate and early post operative period. Chordal sparing mitral valve replacement 
has been established to protect the left ventricular systolic and diastolic function in the late 
postoperative period.
  A well designed prospective trial with a larger group of patients and a longer follow up period is 
needed to evaluate further this technique.
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Anatomy of Mitral Valve
Base of Heart with Atria Removed
Anatomy of Mitral Valve With 
Sub Valvular Apparatus
View of St.Judes Prosthetic Mitral Valve
Severe Subvalvular Fusion
Stenotic Valve
Severe Fibrosis with Subchordal Fusion
Thickened  Valve leaflet with Fused Chordae
Anterior Mitral Leaflet being Excised
Chordal Preservation after Excision of AML
Complete Excision of Subvalvular Apparatus
Continuous Suture Technique
Interrupted Suturing Technique
Chordal Preservation Technique (PML Preserved)
Chordal Preservation Technique with Interrupted Sutures
After  Mitral Replacement View of  St. Jude valve
Trans Thoracic Echo short axis view showing 
Fish mouth appearance in MS
Trans Thoracic Echo Long Axis view showing Doming of AML
Trans Thoracic Echo Doppler Showing severe MS
Trans Thoracic Echo Doppler Showing Severe MR
APPENDIX - 2
ACC - Aortic cross clamp
AHA - American Heart Association
AF - Atrial fibrilation
AML - Anterior mitral leaflet
AV - Atrioventricular
EF - Ejection fraction
IMR - Ischemic mitral regurgitation
LA - Left atrium
LV - Left ventricle
LVeSD - Left ventricular end systolic dimension
LVeDD - Left ventricular end diastolic dimension
LVOTO - Left ventricular out flow tract obstruction
MRI - Magnetic resonance imaging
MR - Mitral regurgitation
MS - Mitral stenosis
MV - Mitral valve
MVP - Mitral valve prolapse
MVR - Mitral valve replacement
NYHA- New York Heart Association
PML - Posterior mitral leaflet
PTFE - Poly tetra fluro ethylene
RHD - Rheumatic heart disease
RF - Rheumatic fever
SA - Sinoatrial
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